Atrium Firm PVC Thoracic Catheter 28French-Intended to facilitate the evacuation of air and/or fl...
FDA Device Recall #Z-1297-2022 — Class II — April 21, 2022
Recall Summary
| Recall Number | Z-1297-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 21, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Atrium Medical Corporation |
| Location | Merrimack, NH |
| Product Type | Devices |
| Quantity | 56 cases (560 units / 10 units per case) |
Product Description
Atrium Firm PVC Thoracic Catheter 28French-Intended to facilitate the evacuation of air and/or fluid from the chest cavity or mediastinum. Product REF Number: 15028
Reason for Recall
Mismatch between the expiration date on the sterile barrier pouch and the expiration date on the case/shipper label. Product sterile barrier pouch label expiration date of 16SEP2024 (2024-09-16) while the case and shipper labels both showed 21SEP2024 (2024-09-21), causing product being used for up to five (5) days past the true expiration date
Distribution Pattern
AZ IL KS LA MI NY OH OK TX VA
Lot / Code Information
UDI-DI: 20650862150289 - case / 00650862150285- each Lot Number: ME231010
Other Recalls from Atrium Medical Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0024-2025 | Class II | iCast Covered Stent, 6MMx16MMx120CM, Model Numb... | Sep 9, 2024 |
| Z-1960-2024 | Class II | ADVANTA VXT, 7X70, 1GDS, NH, STR-SW. Single-End... | May 3, 2024 |
| Z-1951-2024 | Class II | ADVANTA VXT, 5X40, 1GDS, NH, STR-SW. Single-End... | May 3, 2024 |
| Z-1989-2024 | Class II | ADVANTA VXT, 6X80, 1GDS, FH, STR-TW. Single-End... | May 3, 2024 |
| Z-1954-2024 | Class II | ADVANTA VXT, 5X50, 1GDS, NH, STR-SW. Single-End... | May 3, 2024 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.